Phenotyping breast cancer cell lines EM-G3, HCC1937, MCF7 and MDA-MB-231 using 2-D electrophoresis and affinity chromatography for glutathione-binding proteins
Tóm tắt
Transformed phenotypes are common to cell lines derived from various cancers. Proteome profiling is a valuable tool that may reveal uncharacteristic cell phenotypes in transformed cells. Changes in expression of glutathione S-transferases (GSTs) and other proteins interacting with glutathione (GSH) in model cell lines could be of particular interest. We compared the phenotypes of breast cell lines EM-G3, HCC1937, MCF7 and MDA-MB-231 using 2-D electrophoresis (2-DE). We further separated GSH-binding proteins from the cell lines using affinity chromatography with GSH-Sepharose 4B, performed 2-DE analysis and identified the main protein spots. Correlation coefficients among 2-DE gels from the cell lines were lower than 0.65, pointing to dissimilarity among the cell lines. Differences in primary constituents of the cytoskeleton were shown by the 2-D protein maps and western blots. The spot patterns in gels of GSH-binding fractions from primary carcinoma-derived cell lines HCC1937 and EM-G3 were similar to each other, and they differed from the spot patterns of cell lines MCF7 and MDA-MB-231 that were derived from pleural effusions of metastatic mammary carcinoma patients. Major differences in the expression of GST P1-1 and carbonyl reductase [NADPH] 1 were observed among the cell lines, indicating differential abilities of the cell lines to metabolize xenobiotics. Our results confirmed the applicability of targeted affinity chromatography to proteome profiling and allowed us to characterize the phenotypes of four breast cancer cell lines.
Tài liệu tham khảo
Lacroix M, Leclercq G: Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat. 2004, 83: 249-289. 10.1023/B:BREA.0000014042.54925.cc.
Burdall SE, Hanby AM, Lansdown MRJ, Speirs V: Breast cancer cell lines: friend or foe?. Breast Cancer Res. 2003, 5: 89-95. 10.1186/bcr577.
Patterson SD, Aebersold RH: Proteomics: the first decade and beyond. Nature Genet. 2003, 33: 311-323. 10.1038/ng1106.
Slany A, Haudek VJ, Zwickl H, Gundacker NC, Grusch M, Weiss TS, Seir K, Rodgarkia-Dara C, Hellerbrand C, Gerner C: Cell characterization by proteome profiling applied to primary hepatocytes and hepatocyte cell lines Hep-G2 and Hep-3B. J Proteome Res. 2010, 9: 6-21. 10.1021/pr900057t.
Hathout Y, Gehrmann ML, Chertov A, Fenselau C: Proteomic phenotyping: metastatic and invasive breast cancer. Cancer Lett. 2004, 210: 245-253. 10.1016/j.canlet.2004.01.019.
Gorg A, Drews O, Luck C, Weiland F, Weiss W: 2-DE with IPGs. Electrophoresis. 2009, 30 (Suppl 1): S122-S132.
Weiss W, Gorg A: High-resolution two-dimensional electrophoresis. Methods Mol Biol. 2009, 564: 13-32. full_text.
Zuo X, Echan L, Hembach P, Tang HY, Speicher KD, Santoli D, Speicher DW: Towards global analysis of mammalian proteomes using sample prefractionation prior to narrow pH range two-dimensional gels and using one-dimensional gels for insoluble and large proteins. Electrophoresis. 2001, 22: 1603-1615. 10.1002/1522-2683(200105)22:9<1603::AID-ELPS1603>3.0.CO;2-I.
Lee WC, Lee KH: Applications of affinity chromatography in proteomics. Anal Biochem. 2004, 324: 1-10. 10.1016/j.ab.2003.08.031.
Collinsova M, Castro C, Garrow TA, Yiotakis A, Dive V, Jiracek J: Combining combinatorial chemistry and affinity chromatography: highly selective inhibitors of human betaine: homocysteine S-methyltransferase. Chem Biol. 2003, 10: 113-122. 10.1016/S1074-5521(03)00008-5.
Di Pietro G, Magno LA, Rios-Santos F: Glutathione S-transferases: an overview in cancer research. Expert Opin Drug Metab Toxicol. 2010, 6: 153-170. 10.1517/17425250903427980.
Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL: Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem. 2009, 390: 191-214. 10.1515/BC.2009.033.
Marahatta SB, Punyarit P, Bhudisawasdi V, Paupairoj A, Wongkham S, Petmitr S: Polymorphism of glutathione S-transferase omega gene and risk of cancer. Cancer Lett. 2006, 236: 276-281. 10.1016/j.canlet.2005.05.020.
Buser K, Joncourt F, Altermatt HJ, Bacchi M, Oberli A, Cerny T: Breast cancer: pretreatment drug resistance parameters (GSH-system, ATase, P-glycoprotein) in tumor tissue and their correlation with clinical and prognostic characteristics. Ann Oncol. 1997, 8: 335-341. 10.1023/A:1008202723066.
Chekhun VF, Zhylchuk VE, Lukyanova NY, Vorontsova AL, Kudryavets YI: Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients. Exp Oncol. 2009, 31: 123-124.
Mahajan S, Atkins WM: The chemistry and biology of inhibitors and pro-drugs targeted to glutathione S-transferases. Cell Mol Life Sci. 2005, 62: 1221-1233. 10.1007/s00018-005-4524-6.
Soule HD, Vazguez J, Long A, Albert S, Brennan M: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst. 1973, 51: 1409-1416.
Cailleau R, Young R, Olive M, Reeves WJ: Breast tumor cell lines from pleural effusions. J Natl Cancer Inst. 1974, 53: 661-674.
Horie K, Urano T, Ikeda K, Inoue S: Estrogen-responsive RING finger protein controls breast cancer growth. J Steroid Biochem Mol Biol. 2003, 85: 101-104. 10.1016/S0960-0760(03)00209-7.
Rochefort H, Glondu M, Sahla ME, Platet N, Garcia M: How to target estrogen receptor-negative breast cancer?. Endocrine-Related Cancer. 2003, 10: 261-266. 10.1677/erc.0.0100261.
Tomlinson GE, Chen TTL, Stastny VA, Virmani AK, Spillman MA, Tonk V, Blum JL, Schneider NR, Wistuba II, Shay JW, Minna JD, Gazdar AF: Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Res. 1998, 58: 3237-3242.
Brozova M, Kleibl Z, Netikova I, Sevcik J, Scholzova E, Brezinova J, Chaloupkova A, Vesely P, Dundr P, Zadinova M, Krasna L, Matouskova E: Establishment, growth and in vivo differentiation of a new clonal human cell line, EM-G3, derived from breast cancer progenitors. Breast Cancer Res Treat. 2006, 103: 247-257. 10.1007/s10549-006-9358-x.
Selicharova I, Smutna K, Sanda M, Ubik K, Matouskova E, Bursikova E, Brozova M, Vydra J, Jiracek J: 2-DE analysis of a new human cell line EM-G3 derived from breast cancer progenitor cells and comparison with normal mammary epithelial cells. Proteomics. 2007, 7: 1549-1559. 10.1002/pmic.200600907.
Matouskova E, Dudorkinova D, Krasna L, Vesely P: Temporal in vitro expansion of the luminal lineage of human mammary epithelial cells achieved with the 3T3 feeder layer technique. Breast Cancer Res Treat. 2000, 60: 241-249. 10.1023/A:1006409605067.
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976, 72: 248-254. 10.1016/0003-2697(76)90527-3.
Habig WH, Pabst MJ, Jakoby WB: Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974, 249: 7130-7139.
Rabilloud T: A Comparison Between Low Background Silver Diammine and Silver-Nitrate Protein Stains. Electrophoresis. 1992, 13: 429-439. 10.1002/elps.1150130190.
Candiano G, Bruschi M, Musante L, Santucci L, Ghiggeri GM, Carnemolla B, Orecchia P, Zardi L, Righetti PG: Blue silver: A very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis. 2004, 25: 1327-1333. 10.1002/elps.200305844.
Challapalli KK, Zabel C, Schuchhardt J, Kaindl AM, Klose J, Herzel H: High reproducibility of large-gel two-dimensional electrophoresis. Electrophoresis. 2004, 25: 3040-3047. 10.1002/elps.200405979.
Williams K, Chubb C, Huberman E, Giometti CS: Analysis of differential protein expression in normal and neoplastic human breast epithelial cell lines. Electrophoresis. 1998, 19: 333-343. 10.1002/elps.1150190231.
Vydra J, Selicharova I, Smutna K, Sanda M, Matouskova E, Bursikova E, Prchalova M, Velenska Z, Coufal D, Jiracek J: Two-dimensional electrophoretic comparison of metastatic and non-metastatic human breast tumors using in vitro cultured epithelial cells derived from the cancer tissues. BMC Cancer. 2008, 8: 107-10.1186/1471-2407-8-107.
Gilbert L, Elwood LJ, Merino M, Masood S, Barnes R, Steinberg SM, Lazarous DF, Pierce L, d'Angelo T, Moscow JA: A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. J Clin Oncol. 1993, 11: 49-58.
Forrester LM, Hayes JD, Millis R, Barnes D, Harris AL, Schlager JJ, Powis G, Wolf CR: Expression of glutathione S-transferases and cytochrome P450 in normal and tumor breast tissue. Carcinogenesis. 1990, 11: 2163-2170. 10.1093/carcin/11.12.2163.
Bateman RL, Rauh D, Tavshanjian B, Shokat KM: Human carbonyl reductase 1 is an S-nitrosoglutathione reductase. J Biol Chem. 2008, 283: 35756-35762. 10.1074/jbc.M807125200.
Johansson M, Lundberg M: Glutathionylation of beta-actin via a cysteinyl sulfenic acid intermediary. BMC Biochem. 2007, 8: 26-10.1186/1471-2091-8-26.
Ejiri S: Moonlighting functions of polypeptide elongation factor 1: from actin bundling to zinc finger protein R1-associated nuclear localization. Biosci Biotechnol Biochem. 2002, 66: 1-21. 10.1271/bbb.66.1.
Koonin EV, Mushegian AR, Tatusov RL, Altschul SF, Bryant SH, Bork P, Valencia A: Eukaryotic translation elongation factor 1 gamma contains a glutathione transferase domain--study of a diverse, ancient protein superfamily using motif search and structural modeling. Protein Sci. 1994, 3: 2045-2054. 10.1002/pro.5560031117.
Zhang W, Wang L, Liu Y, Xu J, Zhu G, Cang H, Li X, Bartlam M, Hensley K, Li G, Rao Z, Zhang XC: Structure of human lanthionine synthetase C-like protein 1 and its interaction with Eps8 and glutathione. Genes Dev. 2009, 23: 1387-1392. 10.1101/gad.1789209.
Chung CH, Kurien BT, Mehta P, Mhatre M, Mou S, Pye QN, Stewart C, West M, Williamson KS, Post J, Liu L, Wang R, Hensley K: Identification of lanthionine synthase C-like protein-1 as a prominent glutathione binding protein expressed in the mammalian central nervous system. Biochemistry. 2007, 46: 3262-3269. 10.1021/bi061888s.
Warleta F, Campos M, Allouche Y, Sanchez-Quesada C, Ruiz-Mora J, Beltran G, Gaforio JJ: Squalene protects against oxidative DNA damage in MCF10A human mammary epithelial cells but not in MCF7 and MDA-MB-231 human breast cancer cells. Food Chem Toxicol. 2010, 48: 1092-1100. 10.1016/j.fct.2010.01.031.
Pichot CS, Hartig SM, Xia L, Arvanitis C, Monisvais D, Lee FY, Frost JA, Corey SJ: Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells. Br J Cancer. 2009, 101: 38-47. 10.1038/sj.bjc.6605101.
Aroui S, Brahim S, Waard MD, Kenani A: Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: a comparative study. Biochem Biophys Res Commun. 2010, 391: 419-425. 10.1016/j.bbrc.2009.11.073.
Huang Y, Hager ER, Phillips DL, Dunn VR, Hacker A, Frydman B, Kink JA, Valasinas AL, Reddy VK, Marton LJ, Casero RA, Davidson NE: A novel polyamine analog inhibits growth and induces apoptosis in human breast cancer cells. Clin Cancer Res. 2003, 9: 2769-2777.
Susila A, Chan H, Loh AX, Phang HQ, Wong ET, Tergaonkar V, Koh CG: The POPX2 phosphatase regulates cancer cell motility and invasiveness. Cell Cycle. 2010, 9: 179-187.
Mineva ND, Wang X, Yang S, Ying H, Xiao ZX, Holick MF, Sonenshein GE: Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation. J Cell Physiol. 2009, 220: 593-599. 10.1002/jcp.21765.
Wilchek M, Miron T, Kohn J: Affinity chromatography. Methods Enzymol. 1984, 104: 3-55. full_text.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/10/449/prepub